Julie G. Allickson MBBS, PhD, MS, MT

Dr. Julie G. Allickson, Ph.D., is the Michael S. and Mary Sue Shannon Family Director for Regenerative Medicine at the Mayo Clinic. In this role, Dr. Allickson leads the next phase of development of the Center for Regenerative Biotherapeutics as it delivers innovations that cure, connect and transform patient care in alignment with Mayo Clinic's 2030 vision.

Dr. Allickson joined Mayo Clinic from the Wake Forest Institute for Regenerative Medicine at Wake Forest School of Medicine, where she was the chief manufacturing development center officer.

An experienced scientist with regulatory expertise, she has more than 25 years of experience in the clinical translation of cellular therapies and regenerative medicine products, including business management, board directorship experience, and knowledge of regulatory affairs, strategic planning, project management, and team building.

Dr. Allickson directs the enterprisewide biomanufacturing strategy that aspires to introduce new regenerative therapeutics into the practice, providing regenerative medicine therapies for rare and complex conditions — particularly for patients who need specialized, best-in-class care.

By designing, developing, and facilitating alliances for regenerative medicine therapies, Dr. Allickson helps make new treatments available to patients worldwide, including those in underserved communities.